Cintirorgon (LYC-55716) is an orally active RORgamma agonist with potential immunomodulatory and antineoplastic activities. LYC-55716 selectively binds to the RORg, and binds to ROR response elements, enhancing the function, proliferation, and survival of

SPR inhibitor 3是一类用于抑制Sepiapterin reductase活性的小分子化合物，可阻断四氢生物蝶呤（BH4）的生物合成途径，影响一氧化氮合酶及单胺类神经递质的生成。

RORγt Inverse agonist 10 is a highly potent and orally bioavailable compound that acts as an antagonist for the retinoic acid receptor-related orphan nuclear receptor gamma t (RORγt). With an IC50 of 51 nM, it effectively inhibits the activity of RORγt, a prominent transcription factor involved in the regulation of genes associated with the pathogenesis of psoriasis, including IL-17A, IL-22, and IL-23R.

ALR2-IN-10 (Compound 23) 是一种对醛糖还原酶 2 (Aldose Reductase 2) 具有低效抑制作用的化合物，抑制率在 27μM 浓度下为 6%。ALR2-IN-10 可用于糖尿病并发症研究。

TMP778 is an effective and selective RORγt inverse agonist (IC50: 7 nM in FRET assay).

RORγt inverse agonist 23, an orally available novel retinoic acid receptor-related orphan receptor γt inverse agonist, is a potent and selective RORγt inverse agonist.